Abstract:Objective:To compare the expression of the serum antinucleosome antibody family by enzyme-linked immunosorbent assay between the healthy controls and patients with systemic lupus erythematosus(SLE),to analyze the relationship of the serum antinucleosome antibody family and the organ or system damage in SLE,and to define the role of apoptosis in the relationships.Methods: SLE inpatients were selected from two tertiary A-level hospitals,and normal healthy volunteers were recruited as controls.Annexin V(AV) and propidium iodide(PI) were used to detect the early apoptosis rate of peripheral blood mononuclear cells(PBMCs).Serum soluble antinucleosome antibodies,anti-double-stranded DNA antibodies,and antihistone antibodies activities were assessed by Sandwich-enzyme-linked immunosorbent assay(ELISA).Association of the expression of serum antinucleosome antibody family and SLEDAI in SLE patients was analyzed by a multiple linear regression.Results: The prevalence rates of antinucleosome antibody family in SLE patients and normal healthy controls were 68.42% and 0.00% for antinucleosome antibody,53.95% and 0.00% for anti-dsDNA antibody,44.74% and 0.00% for antihistone antibody,respectively.Higher levels of antinucleosome antibodies(81.697±86.256 IU/ml,101.957±97.431 IU/ml,respectively),anti-dsDNA antibodies(266.881±366.684 IU/ml,286.483±279.298 IU/ml,respectively) and antihistone antibodies(45.421±58.262 IU/ml,64.257±69.976 IU/ml,respectively) were found in SLE patients of inactive group and active group compared with those in normal healthy controls(10.106±0.5348 IU/ml,20.034±12.075 IU/ml,9.290±1.281 IU/ml,respectively).No significant difference of serum levels of antinucleosome antibodies,anti-dsDNA antibodies and antihistone antibodies were found in SLE patients between active group and inactive group..There was a positive correlation between the serum levels of antihistone antibodies and SLEDAI(r=0.251,t=2.234,P=0.029).The multiple linear regression for the SLEDAI in SLE patients showed that the levels of serum antinucleosome antibodies might serve as predictors of SLEDAI in SLE patients.On the other hand,the levels of anti-dsDNA antibodies might serve as predictors of SLEDAI in active SLE patients.Conclusion: The expression of serum antinucleosome antibodies,anti-dsDNA antibodies and antihistone antibodies increased in patients with SLE,and there is a positive correlation between the serum levels of antinucleosome antibody family and the early apoptosis rate of PBMCs.The levels of serum antinucleosome antibodies might serve as predictors of SLEDAI in SLE patients.On the other hand,the levels of anti-dsDNA antibodies might serve as predictors of SLEDAI in active SLE patients.

Correlation of Serum B Cell Activating Factor with Disease Activity in Patients with Systemic Lupus Erythematosus

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

The Correlation Between the Serum Collagen Type Ⅳ and Laminin Levels and Disease Activity in Systemic Lupus Erythematosus

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Serum Level of Leptin in Patients with Systemic Lupus Erythematosus:Correlated with Lupus Activity

Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value

Study of T-lymphocyte Activation and Correlation with Disease Activity in Patients with Systemic Lupus Erythematosus

BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus

Levels of Soluble Interleukin-2 Receptor and Clinical Significance in Patients with Systemic Lupus Erythematosus

Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia.

[Increased Serum C-C Chemokine Ligand 19 Levels Correlated with B Cell Abnormalities in Systemic Lupus Erythematosus].

Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus

Association of Expression of Serum Antinucleosome Antibody Family and SLE Disease Activity Index

BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis

Altered Frequency of Peripheral B-cell Subsets and Their Correlation with Disease Activity in Patients with Systemic Lupus Erythematosus: A Comprehensive Analysis.

The Expression of Interferon-Αin the Peripheral Blood and Correlation with Disease Activity in Systemic Lupus Erythematosus Patients

Significance and distribution of lymphopenia and anti-lymphocyte antibody in systemic lupus erythematosus

Correlation of serum acute amyloid A level and activity of Behcet's disease

Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus

Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.

The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity